Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study (2018) Stoehr R, Weisser R, Wendler OD, Giedl J, Daifalla K, Gaisa NT, Richter G, et al. Journal article Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al. Journal article Long noncoding RNA HOTAIR is upregulated in an aggressive subgroup of gastrointestinal stromal tumors (GIST) and mediates the establishment of gene-specific DNA methylation patterns (2018) Bure I, Geer S, Knopf J, Roas M, Henze S, Stroebel P, Agaimy A, et al. Journal article Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential (2018) Muenzner JK, Kunze P, Lindner P, Polaschek S, Menke K, Eckstein M, Geppert CI, et al. Journal article Fatal Encephalitis Associated with Borna Disease Virus 1 (2018) Korn K, Coras R, Bobinger T, Herzog SM, Lücking H, Stoehr R, Huttner H, et al. Journal article CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) Worst TS, Weis CA, Stoehr R, Bertz S, Eckstein M, Otto W, Breyer J, et al. Journal article Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials (2018) Von Den Gruen JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, et al. Journal article Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS) (2018) Gebrekidan M, Erber R, Hartmann A, Fasching P, Emons J, Beckmann M, Bräuer A Journal article The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) Brennan M, Gaß P, Häberle L, Wang D, Hartmann A, Lux MP, Beckmann M, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article